Healthcare industry

Political opposition from both Britain and America could derail any attempt at a deal, especially given the backdrop of the Covid-19 outbreak. The timing is also questionable, as while Gilead is in the middle of a turnaround, AstraZeneca is well positioned and has a strong pipeline, analysts said.

PE firms, including Apollo, Cerberus, and KKR, have acquired hundreds of healthcare companies in recent years, including large hospitals, dermatology clinics and dental practices.

The pandemic has forced patients to avoid hospitals and forgo elective surgeries, which are more lucrative for healthcare providers than emergency services typically related to treatment for Covid-19.

Verizon buys video conferencing platform BlueJeans Network, as more businesses are holding meetings remotely. Biofourmis acquires remote monitoring healthcare company Gaido. Federal Reserve Bank of Minneapolis president Neel Kashkari says that large U.S. banks should raise more capital.

Clearlake, led by co-founders Behdad Eghbali and José E. Feliciano, raises sixth fund. JPMorgan's profit drops from coronavirus impact. Deal news from W20 and Autodesk.

Hospitals are facing higher costs due to spending on equipment like masks, ventilators and medication while revenue has “fallen off a cliff."

Twin Brook, Robert F. Smith, Piper Jaffray win Mid-Market Awards. Eaton Partners shows that LPs are focused on short-term investments. MedZed buys PE-backed health plan provider.

A significant aspect of the emergency and acute care delivery system has mobilized to address the virus while healthcare services focused on non-essential and elective care have been delayed, impacting the M&A landscape for the foreseeable future.

The global healthcare industry will be fundamentally changed by thecoronavirus, which has already infected more than one million patients worldwide.

BorgWarner issues warning to Delphi about the latter drawing from its credit facility, as fears of the coronavirus spreads. The two companies are working towards closing a deal. On the middle market side, we check in with dealmakers from Alvarez & Marsal, Riverside, M33 Growth and Paul Hastings about the potential impact.